DuPontDow ChemicalBASFBayer Syngenta 5 vision ICI

Similar documents
untitled

グラフで見る日本の化学工業 2017

H1-H4

Mizuho Industry Focus Vol

ares_018

FINANCIAL FACT BOOK 2002 CONTENTS CONTENTS Sales Data Net Sales Sales Composition Sales by Region Profit Data Cost Composition & Operating Income/Net

untitled

A Message From President 2


6.indd

橡CATV_1.PDF

Page

15690B_表紙1-4.pdf

66期_00丁付出稿用.indd

Page

untitled

2 24

キャッシュ・フロー経営とキャッシュ・フロー計算書

TPU 10 km BASF

A Message From President 2 Kanamoto examiner vo.18

IDEC Report 2015 IDEC Report 2015

Financial Fact Book

1990 年度 1991 年度 平成 2 年度 平成 3 年度 March 31, 1991 March 31, 1992 米国会計基準 (U.S.GAAP)excludesrestatements 1992 年度 1993 年度 1994 年度 1995 年度 1996 年度 1997 年度 19

4% P % 11.1%1, % %1, %1, % 3.5%1, % %1, % Santen Ph

PERFORMANCE GROWTH MOMENTUM INVESTMENT FOR THE FUTURE 1 CEO 2 COO Performance Growth Momentum


Management Of Technology 1

CONTENTS Financial Performance Financial Result Cosolidated on-consolidated Sales SGA expenses Cosolidated on-consolidated Financial Indicators Cosoli

CONTENTS Financial Performance Financial Result Cosolidated on-consolidated Sales SGA expenses Cosolidated on-consolidated Financial Indicators Cosoli

プルデンシャル生命の現状2008 冒頭編

第112期 決算説明会

サステナビリティ報告書

EPSON Safety Instructions Manual

<836D815B B E95E292D48AD BB A835E838D834F5F4D4B D8CB32E706466>

1. 2. (Rowthorn, 2014) / 39 1

GDP 10 GDP Bureau of Economic Analysis 2

Ł\”ƒ.eps


untitled

38 21

IP Triple Play Copyright 2006, Allied Telesis Holdings, A rights reserved.

untitled

ワークショップ「国際財務報告基準(IFRS)と企業行動:IFRSアドプションのインパクト」の模様

6) 7) MBO management buy-out 2 necessity sufficiency ) 21

Corporate Social Responsibility Report Contents 2 3

RISO P ‘C’³

橡計画0.PDF

Sysmex_Report_2017

Profile PT MANDOM INDONESIA Tbk

GMT_16P_A4

環境報告書

GDP TFP CRD

Financial Data 2012

第1章 製薬産業を取り巻く環境変化

MDGs Millennium Development Goals MDGsMDGs C

8% No

untitled

Page

TECMO,LTD. 2003

⑤香取 徹.indd

untitled

橡バミューダ保険市場(岡崎).PDF

LIFULL アニュアルレポート 2017

FACTA Vorstand 341

業績報告|ディスクロージャー│チューリッヒ|Business Report 2008 会社概要編

J_ANA_ar11納品PDF用 indd

中国市場における日系・欧米系企業の戦略比較


untitled

untitled

untitled

untitled

???

We are the GIBRALTAR. Core Values Worthy of Trust Respect for Each Other Customer Focused Winning

世界経済の見通しと政策課題


M-JUSD2471b

Corporate Philosophy Otsuka-people creating new products for better health worldwide

PowerPoint プレゼンテーション

Quality of Life Human Chemistry, Human Solutions Quality of Life Quality of Life HumanChemistry HumanSolutions ChemistrySol

untitled

Foreword

金融システムレポート(2008年3月号)

目次 Ⅰ. 業界概要 化学産業の沿革 市場構造... 2 Ⅱ. 業界環境 主要企業の特色 収益動向 市場動向 我が国メーカーを取り巻く環境変化... 9 (1) 基礎化学... 9 (2) 機能性化学..

CONTENTS Market Data Fact Book Year ended March 31, 2016 Market Data (Price / Exchange Rate / Stock Markets) 01 Market Data (World) 0

企業価値重視、効率化経営の時代到来へ

1920年代アメリカの新興製造業部門の独占利潤と内部資金

IT IT JUAS

* ,195,393 1,269,415 $8,987,917 45,664 96, ,338 10,679 50,318 80,293 5,180 25,177 38,947 ** 1,193,011 1,240,008 8,970,008


日本の金融市場におけるファンドの活用について ~世界に大きく遅れた日本の運用業界の現状と今後の展望を考える~

2017年12月期 決算説明資料

Microsoft Word - Tuvalu最終.doc

はじめに

GLOBAL FALLOUT 1

海保英孝 69‐91/69‐91

5シンポジウム2001予稿小野寺011121

80% No

和RIMNo.22高安氏.indd

prd s _1253(2).pdf

Transcription:

DuPont Dow Chemical BASF Bayer Syngenta Basic /Utility Conglomerate /Diversified Specialty /Pure-Play Consumer /Retail J/V PER EPS ROE BVPS ROA Financial Leverage Turn Over Margin ROIC 1

DuPontDow ChemicalBASFBayer Syngenta 5 vision 4 10 7 ICI 1993 10 2

3 2005 2

4 2 4 2-1 Middle Middle Risk RiskMiddle Middle Return Return High High Risk RiskHigh High Return Return Specialty Specialty etc. etc. etc. etc. Low Low Risk RiskLow Low Return Return High High Risk RiskLow Low Return Return Commodity Commodity etc. etc. etc. etc. 4

5 / / / /

3-1 DuPont DuPont Dow Chemical BASF Bayer Syngenta 5 Annual report Fact book / Vision 50 2004 USD 1 BASF Germany 40,836 26 Toray Industries Japan 8,254 2 Dow Chemical U.S. 40,161 27 Solvay Belgium 8,066 3 Bayer Germany 28,438 28 Shin-Etsu Japan 7,999 4 ExxonMobil U.S. 27,781 29 Clariant Switzerland 7,378 5 DuPont U.S. 27,340 30 PPG Industries U.S. 7,309 6 Total France 26,656 31 Rohm and Haas U.S. 7,300 7 Royal Dutch/Shell Netherlands;U.K. 21,489 32 Syngenta Switzerland 7,269 8 BP U.K. 20,429 33 Eni Italy 7,205 9 Sinopec China 15,961 34 Air Products U.S. 7,051 10 Sabic Saudi Arabia 15,858 35 Rhodia France 7,024 11 Degussa Germany 14,955 36 Reliance Industries India 6,807 12 Mitsubishi Chemical Japan 14,459 37 Ineos U.K.. 6,650 13 Akzo Nobel Netherlands 12,707 38 Praxair U.S. 6,594 14 Air Liquide France 12,470 39 Eastman Chemical U.S. 6,580 15 Mitsui Chemicals Japan 11,869 40 Asahi Kasei Japan 6,184 16 Formosa Plastics Group Taiwan 11,864 41 Borealis Denmark 6,155 17 Huntsman U.S. 11,486 42 Sherwin-Williams U.S. 6,114 18 ICI U.K. 10,586 43 Ciba Specialty Chemicals Switzerland 6,078 19 Sumitomo Chemical Japan 10,334 44 Lyondell Chemical U.S. 5,968 20 DSM Netherlands 10,310 45 BOC U.K 5,779 21 Koch Industries U.S. 10,000 46 Tosoh Japan 5,648 22 Dainippon Ink & Chemicals Japan 9,373 47 Monsanto U.S. 5,457 23 Equistar Chemicals U.S. 9,316 48 Ashland U.S. 5,397 24 CPChem U.S. 9,238 49 Linde Germany 5,324 25 General Electric U.S. 8,300 50 Nova Chemicals Canada 5,270 Chemical Week / 1802 6 70 40 11 35 / Core Value 6

Vision 3 Mission vision 3 Integrated Science 20 Knowledge Intensity 200 Productivity/Six Sigma 100 3.4 2005 11 COO Chief Operating Officer 10 3 10 CFO Chief Financial Officer ROIC Return On Invested Capital 3%Pt 3 1 18 RONA Return On Net Assets CSTO Chief Science & Technology Officer 3 CMO Chief Marketing Officer 7

5 H.H. Index 50% Other Chemicals 8% Specialty Fibers 11% Polyester Enterprize 17% Others 0% Sales USD27,340million (H.H.Index 1,855) Performance Coating & Polymer 21% Agrochemicals & Nutrition 22% Pigment & Chemicals 21% Asia Pacific 17% North America Sales 46% USD27,340million Europe Africa M.East 29% South America 8% PL CF BS 35% 2004/12 BS Cash 10% A.P. 8% A.R. 14% Debt 18% Inventory 13% Others 39% Fixed Asset 29% Others 35% Equity 35% Total Assets 35,632 20% 15% 10% 5% 0% -5% -10% -15% 10 PL CF (Sales=100%) 12% 11% 6% EBIT Net Income Depreciation & Amortization 16% Cash Flow from Operations -5% Cash Flow from Investments 11% Free Cash Flow -10% Cash Flow from Finance 1% Total Cash Flow 8

SWOT Dow Chemical / 1897 4 175 37 165 / Dow s Essential Elements VisionValues 4 Vision 4 Mission Why We are Here Values Who We are Vision What We Seek to Become What We Intended to Do 4 40% 9

BRICs Agricultural Products 8% Hydro-Carbons 12% Chemicals 14% Others 1% Sales USD40,161million (H.H.Index 1,862) Performance Chemical 17% Plastics 24% Performance Plastics 24% Rest of The World 27% Sales USD40,161million Europe 36% United States 37% PL CF BS DE 1.0 2004/12 BS Cash 7% A.P. 8% A.R. 10% Debt 27% Inventory 11% Fixed Asset 30% Others 35% Others 42% Total Assets Equity 30% 45,885 12% 10% 8% 6% 4% 2% 0% -2% -4% -6% -8% 10 PL CF (Sales=100%) 9% EBIT 5% Net Income Depreciation 6% & Amortization 11% Cash Flow from Operations -5% Cash Flow from Investments 6% Free Cash Flow -5% Cash Flow from Finance 1% Total Cash Flow SWOT 10

BRICs BASF 1865 / 8 170 41 / Mission Vision 4 Value 6 Vision 7 Vision BASF2015 11

Verbund 6 2/3 Crop Protection 9% Oil&Gas 14% Nutrition 5% Chemicals 19% Others 4% Sales USD45,044million (H.H.Index 1,908) Plastic & Fibers 28% Colorants & Fine Products 21% Latin America 5% Asia/Africa 17% North America 22% Germany 20% Sales USD45,044million Other Europe 36% PL CF BS 2004/12 BS 10 PL CF Cash 7% A.P. 7% A.R. 16% Debt 10% Others 37% Inventory 14% Fixed Asset 37% 10% 5% 0% (Sales=100%) 9% 6% 8% 11% 3% 0% Equity 46% -5% -2% Others 27% Total Assets 39,901-10% EBIT Net Income Depreciation & Amortization Cash Flow from Operations -8% Cash Flow from Investments Free Cash Flow Cash Flow from Finance Total Cash Flow 12

SWOT Bayer / 1863 Material Science Health Care Crop Science 3 9 350 / Value 5 Vision 13

14 1997 CVA Cash Valued Added 6.0% 8.5% 6.5% 7.0% 3 Sales USD35,710million (H.H.Index 2,805) Polymers 38% Healthcare 29% Others 2% Chemicals 11% Agriculture 20% Sales USD45,044million Asia 17% S.America Africa 12% North America 28% Europe 43%

PL CF BS Lanxess 2005 1 2004/12 BS 10 PL CF SWOT Syngenta Cash 10% A.P. 6% Debt 26% A.R. 15% Inventory 16% Others 36% Fixed Asset 24% Others 35% Equity 33% Total Assets 44,475 8% 4% Lanxess M&A / 2000 11 Novartis AgriBusiness Ciba Geigy Sandoz Zeneka AgroChemicals ICI 2 90 / 15% 10% 5% 0% -5% -10% -15% (Sales=100%) EBIT Net Income Depreciation 8% & Amortization 11% Cash Flow from Operations Crop Solution -10% Cash Flow from Investments 1% Free Cash Flow 0% Cash Flow from Finance 1% Total Cash Flow 15

16 5 3 Vision PL CF BS Sales USD5,592million (H.H.Index 7,172) Seeds 17% Crop Protection 83% Sales USD5,592million NAFTA 32% Latin America 15% Asia 13% Europe 40%

SWOT 2004/12 BS Cash 2% A.P. 12% A.R. 16% Debt 13% Inventory 18% Others 28% Fixed Asset 18% Others 46% Equity 47% Total Assets 9,237 15% 10% 5% 0% -5% -10% -15% 7 PL CF (Sales=100%) 12% EBIT 4% Net Income Depreciation 7% & Amortization 12% Cash Flow from Operations 6 7 BRICs -2% Cash Flow from Investments 10% Free Cash Flow -9% Cash Flow from Finance 1% Total Cash Flow DuPont Dow Chemical BASF Bayer Syngenta vision 17

18 M&A M.E.Portor Basic Utility BP Exxon Shell Sinopec / / / / / / / / / Conglomerate Diversified Conglomerate Conglomerate Diversified Diversified Consumer Retail Consumer Consumer Retail Retail Basic Utility Basic Basic Utility Utility Specialty Pure-Play Specialty Specialty Pure Pure-Play Play

Conglomerate Diversified Dow ChemicalBASF Specialty Pure-Play DegussaAkzo Syngenta JSR / Consumer Retail P&G 19

DuPont / / 1993 ICI 7 DuPont M&A 100 100 Next century ICI Hoechst BMS 1997 PA/PET 1998 2001 DuPont 1998 1999 2003 Spin Off DuPont Merck KGAA Pioneer Hi-Bred Invista Koch Industries 20

Bayer 3 Chiron Aventis CropScience Lanxess 1998 2001 2004 Spin Off Bayer Bayer 1999 2002 Spin Off Health care Material Crop Science Science Lyondell Haarmann Reimer J/V BASF Shell PP PE Basell S&B Access Industries J/V Wyeth Abbott 2000 2000 BASF 1997 J/V PP Targor 1998 J/V PE Elenac BASF 2002 2000 Basell 2005 Access Industries Bayer 21

M&A 1993 ICI Syngenta ICI Sandoz Ciba 3 No.1 Syngenta 6 Novartis Ciba Specialty Chemicals Astra Zeneca ICI Sandoz Clariant 1995 Spin off 1999 Astra Zeneca 2000 Spin Off Syngenta Ciba Geigy 1997 Spin Off 1997 2000 Spin Off Ciba Geigy Ciba Specialty Novartis Dow Chemical 10 22

Eli Lilly Rohm & Haas 1997 2001 Dow Chemical Dow Chemical 1999 2001 Union Carbide Ascot BP Innovene Ineos Atlantic Richfield Veba Oel 1999 2001 BP BP 1998 1998 2005 Spin Off Amoco Burmah Castrol Innovene Ineos 23

Ineos Innovene Caprihans Norsk Hydro ICI Eni Cytec Chevron 19992001 2005 19971998 2002 2005 Chlor/Silica/ PVC PVC Cumene Fluor/acrylics /acrylics Ineos Ineos 2001 1998 Phenol 2005 2005 2005 EO 2003 PS Salt Inspec Degussa BASF BP Compass Minerals 5 Specialty Akzo Nobel Conglomerate 4 Specialty Formosa Plastics LG Chemical Saudi Basic Industries Reliance Industries 5 2004 2004/12 or 2005/3 2005 12 24

25 PSR PER EPS PER EPS 1 6-2 EPS EPS EPS PER - 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance (billion USD) - 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 (x) Market Capitalization Sales PSR PSR1.0 PER EPS - 5 10 15 20 25 30 35 40 45 50 DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance x - 1 2 3 4 5 6 7 8 9 10 USD EPS PER PER PER

PER PER 1520 PER 30 2 DDM PERd r-g d r g PER r g d ROE BVPS g d rrisk free rate market risk premium risk free rate market risk premium EPS EPSBVPS 1 ROE BVPS BVPS BVPS ROE 30.0% 25.0% BVPS ROE USD 10 9 8 20.0% 7 6 15.0% 5 10.0% 4 3 5.0% 0.0% DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance 2 1-26

ROE ROE ROA Financial Leverage ROE ROEFinancial Leverage ROA ROE Financial Leverage Financial Leverage Financial Leverage ROE ROA Financial Leverage 6-5 Financial Leverage ROA 18.0% 16.0% 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% Financial Leverage ROA (x) 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 2.0% 0.0% DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance 0.5-27

1.0 0.8 0.6 0.4 0.2 - -0.2 (x) Net Capex/Equity Net Working Capital/Equity -0.4-0.6 DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance Turn Over Margin ROA ROAMargin Turn Over 4 12 Margin 4 Specialty Conglomerate Consumer Specialty 28

Tax Management Margin Turn Over 30.0% Turnover Margin (x) 1.4 25.0% 1.2 20.0% 1.0 15.0% 0.8 0.6 10.0% 0.4 5.0% 0.0% DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance 0.2 - (months) 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 - DuPont Dow Cash/Sales*12 Accounts Receivable/Sales*12 Fixed assets/sales*12 Inventory/Sales*12 BASF Bayer Syngenta Akzo FPC LG chem Sinopec (months) 12.0 SABIC Reliance 10.0 8.0 6.0 4.0 2.0-100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% DuPont Dow EBT/EBIT Income/EBT Gross margin/sales EBIT/Gross margin BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance 200.0% 180.0% 160.0% 140.0% 120.0% 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% ROIC ROIC Return On Invested Capital Invested Capital ROA EBIT ROA manageable ROIC ROA 29

ROIC Invested Capital ROA 35.0% 30.0% 25.0% Invested Capital (billion USD) Total Capital 50.0 ROIC 45.0 ROA 40.0 35.0 20.0% 15.0% 30.0 25.0 20.0 10.0% 5.0% 0.0% DuPont Dow BASF Bayer Syngenta Akzo FPC LG chem Sinopec SABIC Reliance 15.0 10.0 5.0-3 Margin Tax Management Invested Capital Financial Flexibility EVA 2 M&A 30

Sustainable growth Sustainable Growth S&B M&A Product Out Market In Strategic Business Unit 31

3 value driver 12 EPS DE 7-1 7-4 DE EPS 32

33 / Follower Leader kenichi.yamaoka@mizuho-cb.co.jp Dow EPS DE -1.0 0.0 1.0 2.0 3.0 4.0 5.0 1995/3/31 1995/9/30 1996/3/31 1996/9/30 1997/3/31 1997/9/30 1998/3/31 1998/9/30 1999/3/31 1999/9/30 2000/3/31 2000/9/30 2001/3/31 2001/9/30 2002/3/31 2002/9/30 2003/3/31 2003/9/30 2004/3/31 2004/9/30 2005/3/31 2005/9/30 (USD/) -30% 0% 30% 60% 90% 120% 150% 180% 12 EPS DE DE UCC DuPont EPS DE -2.0 0.0 2.0 4.0 6.0 8.0 10.0 12.0 1995/3/31 1995/9/30 1996/3/31 1996/9/30 1997/3/31 1997/9/30 1998/3/31 1998/9/30 1999/3/31 1999/9/30 2000/3/31 2000/9/30 2001/3/31 2001/9/30 2002/3/31 2002/9/30 2003/3/31 2003/9/30 2004/3/31 2004/9/30 2005/3/31 2005/9/30 (USD/) -30% 0% 30% 60% 90% 120% 150% 180% 12 EPS DE DE BASF EPS DE 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 1998/3/31 1998/9/30 1999/3/31 1999/9/30 2000/3/31 2000/9/30 2001/3/31 2001/9/30 2002/3/31 2002/9/30 2003/3/31 2003/9/30 2004/3/31 2004/9/30 2005/3/31 2005/9/30 (EUR/) -20% -10% 0% 10% 20% 30% 40% 50% 60% 12 EPS DE DE Bayer EPS DE 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2000/3/31 2000/6/30 2000/9/30 2000/12/31 2001/3/31 2001/6/30 2001/9/30 2001/12/31 2002/3/31 2002/6/30 2002/9/30 2002/12/31 2003/3/31 2003/6/30 2003/9/30 2003/12/31 2004/3/31 2004/6/30 2004/9/30 2004/12/31 2005/3/31 2005/6/30 2005/9/30 (EUR/) -20% 0% 20% 40% 60% 80% 100% 120% 12 EPS DE DE Lanxess